|Bid||3.6000 x 1200|
|Ask||0.0000 x 800|
|Day's Range||4.3500 - 4.3500|
|52 Week Range||1.5000 - 8.4000|
|Beta (5Y Monthly)||0.20|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 25, 2021 - Mar 29, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|Ex-Dividend Date||Nov 13, 2013|
|1y Target Est||21.00|
Reliv International, Inc. (NASDAQ:RELV), a developer and marketer of nutritional supplements that promote optimal health, today announced an update to its plan to suspend its obligations to file periodic and current reports and other information with the U.S. Securities and Exchange Commission (the "Commission") under the Securities Exchange Act of 1934, as amended (the "Exchange Act") and to delist its common stock from trading on the NASDAQ Stock Exchange as previously announced in a press release on October 19, 2020.
This article will reflect on the compensation paid to Ryan Montgomery who has served as CEO of Reliv' International...
Reliv International, Inc. (NASDAQ:RELV), a marketer of nutritional supplements that promote optimal health, today reported its financial results for the third quarter of 2020.